Transplantation of Embryonic Cerebellar Grafts Improves Gait Parameters in Ataxic Lurcher Mice

. 2015 Dec ; 14 (6) : 632-41.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid25700681
Odkazy

PubMed 25700681
DOI 10.1007/s12311-015-0656-x
PII: 10.1007/s12311-015-0656-x
Knihovny.cz E-zdroje

Hereditary cerebellar ataxias are severe diseases for which therapy is currently not sufficiently effective. One of the possible therapeutic approaches could be neurotransplantation. Lurcher mutant mice are a natural model of olivocerebellar degeneration representing a tool to investigate its pathogenesis as well as experimental therapies for hereditary cerebellar ataxias. The effect of intracerebellar transplantation of embryonic cerebellar solid tissue or cell suspension on motor performance in adult Lurcher mutant and healthy wild-type mice was studied. Brain-derived neurotrophic factor level was measured in the graft and adult cerebellar tissue. Gait analysis and rotarod, horizontal wire, and wooden beam tests were carried out 2 or 6 months after the transplantation. Higher level of the brain-derived neurotrophic factor was found in the Lurcher cerebellum than in the embryonic and adult wild-type tissue. A mild improvement of gait parameters was found in graft-treated Lurcher mice. The effect was more marked in cell suspension grafts than in solid transplants and after the longer period than after the short one. Lurcher mice treated with cell suspension and examined 6 months later had a longer hind paw stride (4.11 vs. 3.73 mm, P < 0.05) and higher swing speed for both forepaws (52.46 vs. 32.79 cm/s, P < 0.01) and hind paws (63.46 vs. 43.67 cm/s, P < 0.001) than controls. On the other hand, classical motor tests were not capable of detecting clearly the change in the motor performance. No strong long-lasting negative effect of the transplantation was seen in wild-type mice, suggesting that the treatment has no harmful impact on the healthy cerebellum.

Zobrazit více v PubMed

Nature. 1997 Aug 21;388(6644):769-73 PubMed

Behav Brain Res. 2010 Jun 26;210(1):8-15 PubMed

Behav Brain Res. 2014 Sep 1;271:218-27 PubMed

Dev Neurosci. 1992;14(2):153-65 PubMed

Biochem Biophys Res Commun. 2006 Mar 10;341(2):304-9 PubMed

Cerebellum Ataxias. 2014 Jun 16;1:4 PubMed

Cerebellum Ataxias. 2014 Jun 16;1:3 PubMed

Neurobiol Dis. 2010 Nov;40(2):415-23 PubMed

Nat Rev Neurosci. 2002 May;3(5):401-9 PubMed

Exp Neurol. 1998 Dec;154(2):336-52 PubMed

Neurobiol Learn Mem. 1996 Mar;65(2):113-20 PubMed

Neuroscience. 1987 Jan;20(1):1-22 PubMed

Dev Biol. 2008 May 1;317(1):147-60 PubMed

Neurosci Lett. 2014 Jan 13;558:154-8 PubMed

J Comp Neurol. 2006 Aug 1;497(4):622-35 PubMed

J Neurosci. 2006 Jul 26;26(30):7839-48 PubMed

Brain. 2013 Jun;136(Pt 6):1732-45 PubMed

Cerebellum. 2009 Mar;8(1):35-45 PubMed

J Neurosci. 2009 Oct 21;29(42):13126-35 PubMed

Exp Neurol. 1993 Jul;122(1):165-70 PubMed

Exp Brain Res. 1987;66(2):271-86 PubMed

Cerebellum. 2009 Sep;8(3):137-54 PubMed

Cerebellum. 2014 Jun;13(3):323-30 PubMed

Cell Tissue Res. 2010 May;340(2):357-69 PubMed

Cell Transplant. 1996 Mar-Apr;5(2):269-77 PubMed

Neurosci Lett. 2005 Jun 24;381(3):234-6 PubMed

Exp Neurol. 1999 Aug;158(2):301-11 PubMed

Anat Rec (Hoboken). 2009 Dec;292(12):1986-92 PubMed

Biochem Biophys Res Commun. 1993 Dec 30;197(3):1267-76 PubMed

Neurosci Lett. 2012 Apr 25;515(1):23-7 PubMed

J Biomed Sci. 2011 Aug 08;18:54 PubMed

Cerebellum Ataxias. 2014 Sep 01;1:12 PubMed

Philos Trans R Soc Lond B Biol Sci. 1979 Oct 11;287(1020):167-201 PubMed

Development. 2003 Jan;130(2):391-9 PubMed

Neurology. 2013 Oct 15;81(16):1378-86 PubMed

Neuroreport. 1995 Oct 2;6(14):1827-32 PubMed

Neuroscience. 2001;102(3):615-23 PubMed

Eur J Neurosci. 2005 Feb;21(4):979-88 PubMed

Brain Res. 1982 Nov 4;250(2):358-62 PubMed

Cerebellum. 2005;4(1):2-6 PubMed

J Embryol Exp Morphol. 1982 Apr;68:87-98 PubMed

Med Sci Monit. 2012 May;18(5):BR174-180 PubMed

Neuropharmacology. 2013 Jul;70:1-11 PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Lurcher Mouse as a Model of Cerebellar Syndromes

. 2025 Feb 28 ; 24 (2) : 54. [epub] 20250228

Quantification of Solid Embryonic Cerebellar Graft Volume in a Degenerative Ataxia Model

. 2024 Oct ; 23 (5) : 1811-1823. [epub] 20240302

Reduction of Microvessel Number and Length in the Cerebellum of Purkinje Cell Degeneration Mice

. 2024 Apr ; 23 (2) : 471-478. [epub] 20230418

Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications

. 2022 Jun ; 21 (3) : 452-481. [epub] 20210810

Sonic Hedgehog and Triiodothyronine Pathway Interact in Mouse Embryonic Neural Stem Cells

. 2020 May 23 ; 21 (10) : . [epub] 20200523

Embryonic Cerebellar Graft Morphology Differs in Two Mouse Models of Cerebellar Degeneration

. 2019 Oct ; 18 (5) : 855-865.

Task Force Paper On Cerebellar Transplantation: Are We Ready to Treat Cerebellar Disorders with Cell Therapy?

. 2019 Jun ; 18 (3) : 575-592.

Long-Term Development of Embryonic Cerebellar Grafts in Two Strains of Lurcher Mice

. 2018 Aug ; 17 (4) : 428-437.

Impact of Non-Invasively Induced Motor Deficits on Tibial Cortical Properties in Mutant Lurcher Mice

. 2016 ; 11 (7) : e0158877. [epub] 20160707

Smaller Absolute Quantities but Greater Relative Densities of Microvessels Are Associated with Cerebellar Degeneration in Lurcher Mice

. 2016 ; 10 () : 35. [epub] 20160419

Experimental neurotransplantation treatment for hereditary cerebellar ataxias

. 2016 ; 3 () : 7. [epub] 20160404

Transplantation and Stem Cell Therapy for Cerebellar Degenerations

. 2016 Feb ; 15 (1) : 48-50.

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace